NYSEARCA:MRNY YieldMax MRNA Option Income Strategy ETF (MRNY) Price, Holdings, & News $15.02 -0.58 (-3.72%) As of 11:25 AM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChartDividendHeadlinesHoldingsShort InterestBuy This Stock About YieldMax MRNA Option Income Strategy ETF (NYSEARCA:MRNY) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get MRNY alerts:Sign Up Key Stats Today's Range$14.99▼$15.4050-Day Range$14.85▼$21.3952-Week Range$13.60▼$25.80Volume95,467 shsAverage Volume210,627 shsMarket Capitalization$103.04 millionAssets Under Management$111.08 millionDividend Yield79.96%Net Expense Ratio1.27%Aggregate RatingN/A ETF Overview The YieldMax MRNA Option Income Strategy ETF (MRNY) is an exchange-traded fund that mostly invests in health care equity. The fund seeks to provide current income and capped gains on the Moderna stock (MRNA) through a synthetic covered call strategy, collateralized by cash and US Treasurys. The actively managed fund uses both standardized exchange-traded and FLEX options. MRNY was launched on Oct 23, 2023 and is issued by YieldMax. Read More YieldMax MRNA Option Income Strategy ETF ExpensesTypeMRNYSingle Stock ETFsEquity ETFsNYSEARCA ETFsAll ETFsManagement Fee0.99%0.97%0.57%0.51%0.53%Other Expenses0.28%0.64%0.55%0.58%0.55%Total Expense1.27%1.38%0.76%0.74%0.73%Fee Waiver0.00%-0.97%-0.64%-0.70%-0.62%Net Expense1.27%1.06%0.63%0.58%0.60% Receive MRNY Stock News and Ratings via Email Sign-up to receive the latest news and ratings for YieldMax MRNA Option Income Strategy ETF and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. MRNY ETF News HeadlinesYieldMax MRNA Option Income Strategy ETF (NYSEARCA:MRNY) Stock Price Down 2.7% - What's Next?July 21 at 2:21 AM | americanbankingnews.comYieldMax MRNA option income strategy ETF declares $0.3647 dividendJuly 15, 2026 | msn.comYour book attachedBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time through a temporary download link. He plans to charge for it soon. Download your copy now and lock it in at no cost, regardless of future pricing.July 23 at 1:00 AM | Profits Run (Ad)YieldMax MRNA option income strategy ETF announces weekly distribution of $0.4269July 8, 2026 | msn.comYieldMax MRNA option income strategy ETF announces weekly distribution of $0.3944July 1, 2026 | msn.comMRNY: The Yield Is Too Aggressive For Long-Term SustainabilityJune 26, 2026 | seekingalpha.comSee More Headlines MRNY ETF - Frequently Asked Questions How have MRNY shares performed this year? YieldMax MRNA Option Income Strategy ETF's stock was trading at $14.70 at the beginning of the year. Since then, MRNY shares have increased by 3.1% and is now trading at $15.15. When did YieldMax MRNA Option Income Strategy ETF's stock split? YieldMax MRNA Option Income Strategy ETF's stock reverse split on the morning of Monday, December 1st 2025.A 1-10 reverse split was announced. The number of shares owned by shareholders was adjusted after the closing bell on Sunday, November 30th 2025. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split. How do I buy shares of YieldMax MRNA Option Income Strategy ETF? Shares of MRNY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of YieldMax MRNA Option Income Strategy ETF own? Based on aggregate information from My MarketBeat watchlists, some other companies that YieldMax MRNA Option Income Strategy ETF investors own include YieldMax NVDA Option Income Strategy ETF (NVDY), YieldMax COIN Option Income Strategy ETF (CONY), YieldMax META Option Income Strategy ETF (FBY), Defiance Nasdaq 100 Enhanced Options & 0DTE Income ETF (QQQY), JPMorgan Nasdaq Equity Premium Income ETF (JEPQ), Oxford Lane Capital (OXLC) and YieldMax AMZN Option Income Strategy ETF (AMZY). Fund Details IssuerElevate Shares Fund NameYieldMax MRNA Option Income Strategy ETF Tax ClassificationRegulated Investment Company Stock ExchangeNYSEARCACurrent SymbolNYSEARCA:MRNY Inception Date10/23/2023 Fund ManagerMick Brokaw, Jay Pestrichelli, Qiao Duan, Charles Ragauss WebN/A PhoneN/AFund Focus Asset ClassEquity BenchmarkN/A CategoryStrategy FocusSingle Stock Development LevelDeveloped Markets RegionNorth America Number of Holdings14 Fund Statistics Assets Under Management$111.08 million Average Daily Volume$0.00 Discount/Premium-0.23% Administrator, Advisor and Custodian AdministratorTidal ETF Services, LLC AdvisorTidal Investments, LLC CustodianU.S. Bank, N.A. DistributorForeside Fund Services, LLC Transfer AgentU.S. Bancorp Fund Services, LLC TrusteeN/A Lead Market MakerCitadel Options OptionableOptionable Options Volume14 Put Options4 Call Options10 Short Interest119,843 shs Miscellaneous Outstanding Shares6,860,000Beta-0.18 Creation Fee$300.00 Don't Wait for the OpenAI IPOThe AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.Get This Free Report Top 10 MRNY HoldingsMrna 09/18/2026 75.01 CHolding Weight: 30.26%United States Treasury Bills 0%Holding Weight: 21.78%United States Treasury Bills 0%Holding Weight: 20.92%United States Treasury Bills 0%Holding Weight: 18.42%OTHER ASSETS AND LIABILITIESHolding Weight: 16.97%United States Treasury Bills 0%Holding Weight: 14.38%United States Treasury Bills 0%Holding Weight: 12.50%First American Government Obligations FundHolding Weight: 4.91%MRNA US 07/17/26 C75Holding Weight: 1.22%MRNA US 07/17/26 C77Holding Weight: 0.60%Full Holdings Details This page (NYSEARCA:MRNY) was last updated on 7/23/2026 by MarketBeat.com Staff. From Our PartnersLouis Navellier: My #1 AI stock for 2026 (name & ticker inside)Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...InvestorPlace | SponsoredTrump Takes Emergency Action - Plus Elon Musk's New VentureElon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...Altimetry | SponsoredYour $29.97 book is free todayWhy Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options ca...Profits Run | SponsoredReady to give options a try? Your first trade (Ticker included) -INSIDETired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...Base Camp Trading | SponsoredSPCX Warning - and Worst News for Stocks in 50 YearsGoldman Sachs and Morgan Stanley are now predicting what could be the worst news for the U.S. stock market in ...TradeSmith | SponsoredCODE RED: AI Meltdown Imminent?After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...Paradigm Press | SponsoredElon’s new "tollbooth"The SpaceX IPO was valued at $1.75 trillion. But one analyst says fighting over those shares may be the wrong ...Weiss Ratings | SponsoredElon's new "super startup"Adam O'Dell - the analyst who recommended Palantir before it became the top S&P 500 performer - has identified...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding YieldMax MRNA Option Income Strategy ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share YieldMax MRNA Option Income Strategy ETF With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
